You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

iCasp9

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Pleural Disease, Mesothelioma, Metastases Trial in United States (iCasp9M28z T cell infusions, cyclophosphamide,

Active, not recruiting
  • Malignant Pleural Disease
  • +4 more
  • iCasp9M28z T cell infusions
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
Nov 14, 2022

Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • iCaspase9-transduced T cells
  • AP1903
  • Houston, Texas
  • +1 more
Jul 22, 2022

Leukemia, Myeloma, Myeloproliferative Diseases Trial in Houston (drug, procedure, behavioral)

Terminated
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 24, 2019

B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,

Active, not recruiting
  • B-Lymphoid Malignancies
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 1, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Glioma of Spinal Cord, Glioma of Brainstem Trial in Stanford (GD2 CAR T cells, Fludarabine, Cyclophosphamide)

Recruiting
  • Glioma of Spinal Cord
  • Glioma of Brainstem
  • GD2 CAR T cells
  • +2 more
  • Stanford, California
    Lucile Packard Children's Hospital (LPCH)
Jun 22, 2022

Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,

Recruiting
  • Recurrent Neuroblastoma
  • +3 more
  • Palo Alto, California
  • +3 more
Jan 25, 2023

CD19 Positive, Mantle Cell Lymphoma, Recurrent DLBCL Trial in Houston (procedure, drug, biological)

Withdrawn
  • CD19 Positive
  • +6 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2020

Hematologic Malignancies Trial in Houston (BPX-501, AP1903)

Withdrawn
  • Hematologic Malignancies
  • Houston, Texas
    MD Anderson Cancer Center
Oct 1, 2020

Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

Recruiting
  • Liver Cell Carcinoma
  • +7 more
  • CATCH T cells
  • +2 more
  • Houston, Texas
    Houston Methodist Hospital
Dec 19, 2022

Liver Cancer, Rhabdomyosarcoma, Malignant Rhabdoid Tumor Trial in Houston (CARE T cells, Cytoxan, Fludara)

Not yet recruiting
  • Liver Cancer
  • +5 more
  • CARE T cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Dec 1, 2021

Lymphomas Trial in Gainesville, Beijing (Anti-CD30 CAR T cells)

Unknown status
  • Lymphomas
  • Anti-CD30 CAR T cells
  • Gainesville, Florida
  • +1 more
Oct 22, 2014